John W. LaRocca
2021
In 2021, John W. LaRocca earned a total compensation of $1.5M as General Counsel and Secretary at Aerie Pharmaceuticals, a 54% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $217,522 |
|---|---|
| Option Awards | $583,631 |
| Salary | $451,760 |
| Stock Awards | $194,040 |
| Other | $7,342 |
| Total | $1,454,295 |
LaRocca received $583.6K in option awards, accounting for 40% of the total pay in 2021.
LaRocca also received $217.5K in non-equity incentive plan, $451.8K in salary, $194K in stock awards and $7.3K in other compensation.
Rankings
In 2021, John W. LaRocca's compensation ranked 7,384th out of 12,405 executives tracked by ExecPay. In other words, LaRocca earned more than 40.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,384 out of 12,405 | 41st |
Division Manufacturing | 3,243 out of 5,494 | 41st |
Major group Chemicals And Allied Products | 1,436 out of 2,369 | 39th |
Industry group Drugs | 1,279 out of 2,090 | 39th |
Industry Biological Products, Except Diagnostic Substances | 296 out of 452 | 35th |
Source: SEC filing on April 26, 2022.
LaRocca's colleagues
We found seven more compensation records of executives who worked with John W. LaRocca at Aerie Pharmaceuticals in 2021.
2021
Vicente Anido
Aerie Pharmaceuticals
Chief Executive Officer
2021
Raj Kannan
Aerie Pharmaceuticals
Chief Executive Officer
2021
Thomas Mitro
Aerie Pharmaceuticals
Chief Operating Officer
2021
Casey Kopczynski
Aerie Pharmaceuticals
Chief Innovation Officer, Head of Research and External Innovation
2021
Benjamin McGraw
Aerie Pharmaceuticals
Former Interim Executive Chair
2021
Richard Rubino
Aerie Pharmaceuticals
Chief Financial Officer
2021
Christopher Staten
Aerie Pharmaceuticals
Chief Financial Officer
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019